US Stocks

Horizon Therapeutics Public Limited Company

Horizon Therapeutics is a biotechnology company that develops and commercializes medicines to address the needs of people suffering from autoimmune, rare, and severe inflammatory diseases. The company operates in two segments, namely Orphan and Inflammation, and has a portfolio of 12 medicines for rare diseases, inflammation, ophthalmology, and gout. Horizon Therapeutics collaborates with various companies and has its headquarters in Dublin, Ireland, with additional offices in several locations across the United States and Germany.